Overview
Giridhar Santebennur is an Oncologist practicing medicine in Wheeling, West Virginia.
Dr. Santebennur is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Childhood Iron Deficiency Anemia.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Medical Park, Wheeling, WV 26003
247 Morewood Ave, Pittsburgh, PA 15213
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and WT1-Related Wilms Tumor Syndromes.
Frequently Asked Questions about Dr. Giridhar Santebennur
How do I make an appointment with Dr. Giridhar Santebennur?
You can book an appointment with Dr. Giridhar Santebennur by calling their office at 304-243-6442. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Giridhar Santebennur a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Giridhar Santebennur is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Giridhar Santebennur specialize in?
While Dr. Giridhar Santebennur is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Giridhar Santebennur accept my insurance?
Dr. Giridhar Santebennur accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 304-243-6442 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Childhood Iron Deficiency AnemiaDr. Santebennur isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Santebennur isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Santebennur isDistinguished. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Santebennur isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Santebennur isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Santebennur isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Acute Mountain SicknessDr. Santebennur isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung CancerDr. Santebennur isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Santebennur isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Santebennur isAdvanced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Santebennur isAdvanced. Learn about Antiphospholipid Syndrome.
- B-Cell LymphomaDr. Santebennur isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Santebennur isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Santebennur isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Santebennur isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Santebennur isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Santebennur isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- Anal CancerDr. Santebennur isExperienced. Learn about Anal Cancer.

